4-(3-acetyl-1-benzyl-2-methyl-1H-indol-5-yloxy)butanoic acid

ID: ALA4526073

Chembl Id: CHEMBL4526073

PubChem CID: 155543331

Max Phase: Preclinical

Molecular Formula: C22H23NO4

Molecular Weight: 365.43

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)c1c(C)n(Cc2ccccc2)c2ccc(OCCCC(=O)O)cc12

Standard InChI:  InChI=1S/C22H23NO4/c1-15-22(16(2)24)19-13-18(27-12-6-9-21(25)26)10-11-20(19)23(15)14-17-7-4-3-5-8-17/h3-5,7-8,10-11,13H,6,9,12,14H2,1-2H3,(H,25,26)

Standard InChI Key:  AJGIAOZUTGDMKP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4526073

    ---

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

folA Dihydrofolate reductase (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 365.43Molecular Weight (Monoisotopic): 365.1627AlogP: 4.44#Rotatable Bonds: 8
Polar Surface Area: 68.53Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.08CX Basic pKa: CX LogP: 3.62CX LogD: 0.51
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.47Np Likeness Score: -0.77

References

1. Garg V, Maurya RK, Thanikachalam PV, Bansal G, Monga V..  (2019)  An insight into the medicinal perspective of synthetic analogs of indole: A review.,  180  [PMID:31344615] [10.1016/j.ejmech.2019.07.019]
2. Sharma K, Tanwar O, Deora GS, Ali S, Alam MM, Zaman MS, Krishna VS, Sriram D, Akhter M..  (2019)  Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.,  27  (7): [PMID:30827867] [10.1016/j.bmc.2019.02.053]

Source